The influence of hormone receptor status and HER1 and HER2 expression on the response to neoadjuvant therapy in breast cancer patients

被引：0
|
作者：
Bonigliere, L. [1 ]
Torrisi, R. [1 ]
Pruneri, G. [1 ]
Colleoni, M. [1 ]
Viale, G. [1 ]
机构：
[1] European Inst Oncol, Milan, Italy
来源：
LABORATORY INVESTIGATION | 2008年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
97
引用
收藏
页码：24A / 24A
页数：1
相关论文
共 50 条
  • [1] The influence of hormone receptor status and HER1 and HER2 expression on the response to neoadjuvant therapy in breast cancer patients
    Bouiglieri, L.
    Torrisi, R.
    Pruneri, G.
    Colleoni, M.
    Viale, G.
    MODERN PATHOLOGY, 2008, 21 : 24A - 24A
  • [2] Hormone receptor and HER2 status: The only predictive factors of response to neoadjuvant chemotherapy in breast cancer
    Baulies, S.
    Cusido, M.
    Gonzalez-Cao, M.
    Tresserra, F.
    Fargas, F.
    Rodriguez, I.
    Ubeda, B.
    Ara, C.
    Fabregas, R.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2015, 35 (05) : 485 - 489
  • [3] Discordance in hormone receptor and HER2 status in breast cancer during neoadjuvant chemotherapy
    Maeda, S.
    Tohyama, H.
    Tokai, H.
    Kamohara, Y.
    Nagata, Y.
    Fujioka, H.
    Itoh, M.
    BREAST, 2011, 20 : S73 - S73
  • [4] Changes in Hormone Receptor and Her2 Status After Neoadjuvant Chemotherapy in Breast Cancer
    Kaya, Ali Osman
    Buyukberber, Suleyman
    Yamac, Deniz
    Coskun, Ugur
    Yildiz, Ramazan
    Yaman, Emel
    Ozturk, Banu
    Benekli, Mustafa
    TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2010, 30 (02): : 469 - 473
  • [5] Influence of vitamin D signaling on hormone receptor status and HER2 expression in breast cancer
    Xi Zhang
    Nadia Harbeck
    Udo Jeschke
    Sophie Doisneau-Sixou
    Journal of Cancer Research and Clinical Oncology, 2017, 143 : 1107 - 1122
  • [6] Influence of vitamin D signaling on hormone receptor status and HER2 expression in breast cancer
    Zhang, Xi
    Harbeck, Nadia
    Jeschke, Udo
    Doisneau-Sixou, Sophie
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (07) : 1107 - 1122
  • [7] Influence of Neoadjuvant Therapy with Epirubicin and Docetaxel on the Expression of HER2/neu in Patients with Breast Cancer
    Susanne Taucher
    Margaretha Rudas
    Robert M. Mader
    Michael Gnant
    Emanuel Sporn
    Peter Dubsky
    Sebastian Roka
    Thomas Bachleitner
    Florian Fitzal
    Daniela Kandioler
    Catharina Wenzel
    Günther G. Steger
    Martina Mittlböck
    Raimund Jakesz
    Breast Cancer Research and Treatment, 2003, 82 : 207 - 213
  • [8] Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancer
    Taucher, S
    Rudas, M
    Mader, RM
    Gnant, M
    Sporn, E
    Dubsky, P
    Roka, S
    Bachleitner, T
    Fitzal, F
    Kandioler, D
    Wenzel, C
    Steger, GG
    Mittlböck, M
    Jakesz, R
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 (03) : 207 - 213
  • [9] Impact of neoadjuvant HER2-directed therapy on HER2 status in breast cancer
    Manguso, Nicholas
    Johnson, Jeffrey
    Basho, Reva Kakkar
    McArthur, Heather L.
    Tanaka, Hisashi
    Giuliano, Armando E.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] Her2 low status and response to neoadjuvant chemotherapy in Her2 negative early breast cancer
    Mattos, Bruna RaphaeliSilva
    Cesca, Marcelle Goldner
    Leite, Luciana de Moura
    Tavares, Monique Celeste
    Silva, Sinara Figueiredo
    Pirolli, Rafaela
    Fogassa, Camilla AlbinaZanco
    Silva, Erick Figueiredo
    Rocha, Francisca Giselle
    Loose, Simone Klug
    Campos, Fernando AugustoBatista
    Sanches, Solange Moraes
    de Lima, Vladmir ClaudioCordeiro
    Ponde, Noam Falbel
    CANCER RESEARCH, 2021, 81 (04)
12345